default author photo

Yulin Yang

Shenzhen Beike Biotechnology Co. Ltd.

SCHOLARLY PAPERS

1

DOWNLOADS

80

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Interleukin-18-Primed Human Umbilical Cord-Mesenchymal Stem Cells Achieve Superior Therapeutic Efficacy for Severe Viral Pneumonia Via Enhancing T-Cell Immunosuppression

Number of pages: 45 Posted: 16 Aug 2022
Yan Liao, Zeqin Fu, Yinfu Huang, Shiduo Wu, Zhen Wang, Shaotang Ye, Weijie Zeng, Guifang Zeng, Duanduan Li, Yulin Yang, Ke Pei, Jian Yang, Zhiwei Hu, Xiao Liang, Junyuan Hu, Muyun Liu and Cheguo Cai
Shenzhen Beike Biotechnology Co. Ltd., Shenzhen Beike Biotechnology Co. Ltd., Shenzhen Beike Biotechnology Co. Ltd., Shenzhen Beike Biotechnology Co. Ltd., South China Agricultural University - College of Veterinary Medicine, South China Agricultural University - College of Veterinary Medicine, Shenzhen Beike Biotechnology Co. Ltd., Shenzhen Beike Biotechnology Co. Ltd., Shenzhen Beike Biotechnology Co. Ltd., Shenzhen Beike Biotechnology Co. Ltd., Shenzhen Beike Biotechnology Co. Ltd., Shenzhen Beike Biotechnology Co. Ltd., Shenzhen Beike Biotechnology Co. Ltd., Shenzhen Beike Biotechnology Co. Ltd., Shenzhen Beike Biotechnology Co. Ltd., National-Local Associated Engineering Laboratory for Personalized Cell Therapy and Wuhan University - Department of Thyroid and Breast Surgery
Downloads 80 (803,225)

Abstract:

Loading...

COVID-19, severe pneumonia, IL-18, hUC-MSCs, immunosuppression, precision therapy